Please provide your email address to receive an email when new articles are posted on . A metallo-beta-lactam inhibitor could help fight resistance to beta-lactam antibiotics. MK-3402 was found to be ...
Houston, TX – New research by investigators in Ghent, Belgium shows that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial ...
Pfizer has just completed phase 3 trials of a new antibiotic that's active against highly resistant Gram-negative infections. It's a real superbug fighter. But what took so long? Once upon a time in a ...
Intravenous treatment with MK-3402 can be an effective strategy in fighting antimicrobial resistance
New research by investigators in Ghent, Belgium shows that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial resistance.
MALVERN, Pa.--(BUSINESS WIRE)--Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant ...
Exblifep is a combination product that consists of cefepime, a cephalosporin antibacterial, and enmetazobactam, a beta-lactamase inhibitor. The Food and Drug Administration (FDA) has approved Exblifep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback